Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
26/09/2023 13:41
Sept 26 (Reuters) - Chitogenx Inc CHGX.CD :
* CHITOGENX INC - STUDY RESULTS TO BE AVAILABLE Q3-24 AFTER MANDATORY
POST-SURGERY
MONITORING
* CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR
REPAIR
CLINICAL TRIAL
Further company coverage: CHGX.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chitogenx
See all newsBrief: Chitogenx Announces Signing Of Binding Letter Of Intent With Oligo Medic
Brief: Chitogenx Announces Executive Leadership Changes
Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
Brief: Chitogenx Concludes Enrolment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Brief: Chitogenx Announces New $2.5 Million Non-Brokered Private Placement Offering And Balance Sheet Restructuring